CLAREMONT, Calif., Jan. 18, 2007 (PRIME NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) announces application test effect of its bio-fertilizer products in Shouguang area, Shandong province.
From December 2006, Kiwa started to conduct an application test for set of its water flush bio-fertilizer products in three temperature-keeping greenhouses in Shouguang area, Shandong province. The observation period for the first-round fertilization recently has come to an end. Local agronomists and peasants that participated in application tests are all satisfied with the effect. Compared with other fertilizers used in the test, crops in test groups grew more luxuriantly after being flushed with Kiwa's fertilizers. Local peasants participated in the first-round test all required to extend application test areas, while neighboring temperature-keeping sheds made the same requests as well. Now Kiwa is working on selecting spots for the second-round test and fertilization.
Mr. Wei Li, Board Chairman and CEO of Kiwa, stated: "With 300,000 temperature-keeping sheds for vegetables, Shouguang is one of the largest vegetable shed-planting bases in China with huge potential market for bio-fertilizers. This application test conducted in the Shouguang area is instructed by Mr. Leyi Wang himself, who is a well-known expert of shed-planting, and this test could enable us to enter the Shouguang market in a shorter time. We will spread out our sales in the Shouguang area right after the application test."
About Kiwa Bio-Tech Products Group Corporation
The Company develops, manufactures, and distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development.
For more information, please visit the Company's website at http://www.kiwabiotech.com.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.